These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 34204579)
1. Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect. Stenovec M Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34204579 [TBL] [Abstract][Full Text] [Related]
2. Astrocytes in rapid ketamine antidepressant action. Stenovec M; Li B; Verkhratsky A; Zorec R Neuropharmacology; 2020 Aug; 173():108158. PubMed ID: 32464133 [TBL] [Abstract][Full Text] [Related]
3. Ketamine Action on Astrocytes Provides New Insights into Rapid Antidepressant Mechanisms. Stenovec M; Li B; Verkhratsky A; Zorec R Adv Neurobiol; 2021; 26():349-365. PubMed ID: 34888841 [TBL] [Abstract][Full Text] [Related]
4. Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles. Stenovec M; Božić M; Pirnat S; Zorec R Neurochem Res; 2020 Jan; 45(1):109-121. PubMed ID: 30793220 [TBL] [Abstract][Full Text] [Related]
5. Ketamine Reduces the Surface Density of the Astroglial Kir4.1 Channel and Inhibits Voltage-Activated Currents in a Manner Similar to the Action of Ba Božić M; Pirnat S; Fink K; Potokar M; Kreft M; Zorec R; Stenovec M Cells; 2023 May; 12(10):. PubMed ID: 37408194 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of ketamine action as an antidepressant. Zanos P; Gould TD Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791 [TBL] [Abstract][Full Text] [Related]
7. Ketamine Inhibits ATP-Evoked Exocytotic Release of Brain-Derived Neurotrophic Factor from Vesicles in Cultured Rat Astrocytes. Stenovec M; Lasič E; Božić M; Bobnar ST; Stout RF; Grubišić V; Parpura V; Zorec R Mol Neurobiol; 2016 Dec; 53(10):6882-6896. PubMed ID: 26660497 [TBL] [Abstract][Full Text] [Related]
8. Subanesthetic doses of ketamine stabilize the fusion pore in a narrow flickering state in astrocytes. Lasič E; Rituper B; Jorgačevski J; Kreft M; Stenovec M; Zorec R J Neurochem; 2016 Sep; 138(6):909-17. PubMed ID: 27331380 [TBL] [Abstract][Full Text] [Related]
9. Astrocyte Specific Remodeling of Plasmalemmal Cholesterol Composition by Ketamine Indicates a New Mechanism of Antidepressant Action. Lasič E; Lisjak M; Horvat A; Božić M; Šakanović A; Anderluh G; Verkhratsky A; Vardjan N; Jorgačevski J; Stenovec M; Zorec R Sci Rep; 2019 Jul; 9(1):10957. PubMed ID: 31358895 [TBL] [Abstract][Full Text] [Related]
10. Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine. Cui Y; Hu S; Hu H Trends Neurosci; 2019 Mar; 42(3):179-191. PubMed ID: 30823984 [TBL] [Abstract][Full Text] [Related]
11. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine. Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360 [TBL] [Abstract][Full Text] [Related]
12. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761 [TBL] [Abstract][Full Text] [Related]
13. The role of eEF2 kinase in the rapid antidepressant actions of ketamine. Suzuki K; Monteggia LM Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215 [TBL] [Abstract][Full Text] [Related]
14. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective. Hashimoto K Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725 [TBL] [Abstract][Full Text] [Related]
16. Gliocrine System: Astroglia as Secretory Cells of the CNS. Vardjan N; Parpura V; Verkhratsky A; Zorec R Adv Exp Med Biol; 2019; 1175():93-115. PubMed ID: 31583585 [TBL] [Abstract][Full Text] [Related]
17. Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action. Aleksandrova LR; Wang YT; Phillips AG Chronic Stress (Thousand Oaks); 2017; 1():. PubMed ID: 30556028 [TBL] [Abstract][Full Text] [Related]
18. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038 [TBL] [Abstract][Full Text] [Related]